NCT01384903View on ClinicalTrials.gov

An Open-label Study of KW-3357

PHASE3CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Disseminated Intravascular Coagulation (DIC)
Interventions
DRUG

KW-3357

Intravenous infusion once a day

DRUG

Plasma-derived antithrombin

Intravenous infusion once a day

Trial Locations (1)

Unknown

Saga

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01384903 - An Open-label Study of KW-3357 | Biotech Hunter | Biotech Hunter